Crispr Therapeutics shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by China Universal Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $770k | 16k | 46.98 |
| 2024-06-30 | $539k | 10k | 54.01 |
| 2024-03-31 | $1.1M | 15k | 68.16 |
| 2023-12-31 | $576k | 9.2k | 62.60 |
| 2023-09-30 | $93k | 2.0k | 45.39 |
| 2023-06-30 | $58k | 1.0k | 56.14 |
| 2023-03-31 | $48k | 1.1k | 45.23 |
| 2022-12-31 | $146k | 3.6k | 40.65 |
| 2022-09-30 | $1.6M | 25k | 65.33 |
| 2022-06-30 | $81k | 1.3k | 60.77 |
| 2022-03-31 | $84k | 1.3k | 63.02 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management